SNT 0.00% 3.9¢ syntara limited

Ann: Preliminary Final Report, page-2

  1. 5,663 Posts.
    lightbulb Created with Sketch. 669
    https://www.pharmaceutical-technology.com/comment/current-future-cystic-fibrosis-market/?cf-view

    Vertex has unbelievable market share in cystic fibrosis treatment

    But at least Pharmaxis is well recognised

    keep up the good work Pharmaxis!!!
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.000(0.00%)
Mkt cap ! $46.56M
Open High Low Value Volume
3.9¢ 4.0¢ 3.9¢ $8.125K 204.9K

Buyers (Bids)

No. Vol. Price($)
2 26589 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 209403 1
View Market Depth
Last trade - 10.38am 24/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.